{
  "Q0": "BRCA1/BRCA2 genetic testing",
  "Q1": "Not specified",
  "Q2": "Not specified",
  "Q3": "Yes",
  "Q4": "Yes",
  "Q4.1": "Yes",
  "Q4.1.1": "NCCN",
  "Q5": "Not required",
  "Q6": "No",
  "Q7": "Yes",
  "Q8": "No",
  "Q9": "Yes",
  "Q9.1": "Yes",
  "Q10": "No",
  "Q10.1": "Risk Assessment",
  "Q11": "Not specified",
  "Q12": "No",
  "Q13": "Not specified",
  "Q14": "Not listed",
  "Q15": "No",
  "Q16": "Yes",
  "Q17": "The policy indicates that genetic testing is considered medically necessary when the member displays clinical features or is at direct risk of inheriting the mutation, the test result will directly impact treatment, and after conventional diagnostic studies a definitive diagnosis remains uncertain. The patient should meet disease-specific criteria according to NCCN guidelines for familial high-risk cancer assessment.",
  "match": false
}